Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014919 |
| CAS No | NA |
| Mol.F. | C16H12N6O3 |
| Mol.Wt. | 336.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014920 |
| CAS No | NA |
| Mol.F. | C28H28N8O2 |
| Mol.Wt. | 508.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014921 |
| CAS No | 2816369-80-7 |
| Mol.F. | C28H28N8O2 |
| Mol.Wt. | 508.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014922 |
| CAS No | NA |
| Mol.F. | C16H14N6O |
| Mol.Wt. | 306.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014923 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O4 |
| Mol.Wt. | 514.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014924 |
| CAS No | NA |
| Mol.F. | C23H22ClFN6O4 |
| Mol.Wt. | 500.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014925 |
| CAS No | NA |
| Mol.F. | C26H29N7O4 |
| Mol.Wt. | 503.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014926 |
| CAS No | NA |
| Mol.F. | C26H28N8O5 |
| Mol.Wt. | 532.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014927 |
| CAS No | NA |
| Mol.F. | C26H29N7O4 |
| Mol.Wt. | 503.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014928 |
| CAS No | NA |
| Mol.F. | C30H33N5O3 |
| Mol.Wt. | 511.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N014929 |
| CAS No | NA |
| Mol.F. | C30H28N5O3 |
| Mol.Wt. | 506.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014930 |
| CAS No | NA |
| Mol.F. | C17H15F6N3O2 |
| Mol.Wt. | 407.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014931 |
| CAS No | NA |
| Mol.F. | C28H32N8O3 |
| Mol.Wt. | 528.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014932 |
| CAS No | NA |
| Mol.F. | C27H30N8O3 |
| Mol.Wt. | 514.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014933 |
| CAS No | NA |
| Mol.F. | C27H30N8O3 |
| Mol.Wt. | 514.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014934 |
| CAS No | NA |
| Mol.F. | C27H30N8O3 |
| Mol.Wt. | 514.6 |
| INV STATUS | CUSTOM SYNTHESIS |